Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
Avatar

Challenges of Treating HGBCL Patients with Comorbidities: Who is "FIT" for RCHOP?

By 2018 Pan Pacific Lymphoma Conference FEATURING Laurie H. Sehn
By 2018 Pan Pacific Lymphoma Conference FEATURING Laurie H. Sehn
280 views
August 30, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
High Grade B-cell Lymphoma
19:22

Challenges of Treating HGBCL Patients with Comorbidities: Anthracycl…

2018 Pan Pacific Lymphoma Conference

L. Sehn

192 views
17:51

Optimum Therapy for Standard Risk High Grade - DLBCL

2018 Pan Pacific Lymphoma Conference

N. Bartlett

280 views
10:46

New Approaches to Initial treatment of DLBCL: R-CHOP +

2018 Pan Pacific Lymphoma Conference

N. Bartlett

551 views
15:30

Challenges of Treating HGBCL Patients with Comorbidities: Who is "FI…

2018 Pan Pacific Lymphoma Conference

L. Sehn

280 views
21:17

Burkitt Lymphoma- R-Epoch for All?

2018 Pan Pacific Lymphoma Conference

M. Roschewski

98 views
08:52

Concurrent Systemic and CNS Aggressive NHL: How to Manage?

2018 Pan Pacific Lymphoma Conference

P. Bierman

41 views
26:03

Therapy for Double/Triple Hit-HGBCL

2018 Pan Pacific Lymphoma Conference

S. Smith

218 views
25:59

There is a Role for Lymphoma HDT/ASCT in the New Era of CAR T-cells!

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

209 views
16:20

Is there a role for upfront transplantation in CNS Aggressive NHL

2018 Pan Pacific Lymphoma Conference

P. Bierman

27 views